Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of patients achieving a satisfactory state of minimal disease activity (MDA) is becoming a more important measure with which to compare different treatment strategies. The threshold for MDA is between high disease activity and remission and, by definition, anyone in remission will also be in MDA. True remission is still rare in RA; in addition, the American College of Rheumatology definition is difficult to apply in the context of trials. Participants at OMERACT 6 in 2002 agreed on a conceptual definition of minimal disease activity (MDA): "that state of ...
The MCID (minimal clinically important difference) module of OMERACT 5 developed a research agenda t...
OBJECTIVE: Assessor-based disease activity measures such as the Disease Activity Score in 28 joints ...
In a prospective follow-up study of patients with early-onset rheumatoid arthritis, the prevalence o...
Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and i...
Contains fulltext : 48816.pdf (publisher's version ) (Closed access)Agreement on r...
Objective: To determine the prevalence of minimal disease activity (MDA) and remission in patients w...
The aim of the treatment in rheumatoid arthritis (RA) is to prevent articular damage and functional ...
Objective. To develop and validate a definition of minimal disease activity (MDA) in patients with j...
As very effective targeted biological therapies have become available to treat rheumatoid arthritis ...
OBJECTIVE: To create minimal disease activity (MDA) criteria for psoriatic arthritis (PsA). With rec...
International audienceINTRODUCTION: The aim of this study was to determine a low disease activity th...
Objective. To assess how many PsA patients with an acceptable disease state according to the treatin...
Objective: To comprehensively assess evidence on the measurement properties of the minimal disease a...
Objective: To comprehensively assess evidence on the measurement properties of the minimal disease a...
As in other inflammatory rheumatic diseases, the objective of psoriatic arthritis (PsA) treatment is...
The MCID (minimal clinically important difference) module of OMERACT 5 developed a research agenda t...
OBJECTIVE: Assessor-based disease activity measures such as the Disease Activity Score in 28 joints ...
In a prospective follow-up study of patients with early-onset rheumatoid arthritis, the prevalence o...
Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and i...
Contains fulltext : 48816.pdf (publisher's version ) (Closed access)Agreement on r...
Objective: To determine the prevalence of minimal disease activity (MDA) and remission in patients w...
The aim of the treatment in rheumatoid arthritis (RA) is to prevent articular damage and functional ...
Objective. To develop and validate a definition of minimal disease activity (MDA) in patients with j...
As very effective targeted biological therapies have become available to treat rheumatoid arthritis ...
OBJECTIVE: To create minimal disease activity (MDA) criteria for psoriatic arthritis (PsA). With rec...
International audienceINTRODUCTION: The aim of this study was to determine a low disease activity th...
Objective. To assess how many PsA patients with an acceptable disease state according to the treatin...
Objective: To comprehensively assess evidence on the measurement properties of the minimal disease a...
Objective: To comprehensively assess evidence on the measurement properties of the minimal disease a...
As in other inflammatory rheumatic diseases, the objective of psoriatic arthritis (PsA) treatment is...
The MCID (minimal clinically important difference) module of OMERACT 5 developed a research agenda t...
OBJECTIVE: Assessor-based disease activity measures such as the Disease Activity Score in 28 joints ...
In a prospective follow-up study of patients with early-onset rheumatoid arthritis, the prevalence o...